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Thyrotoxic hypokalemic periodic paralysis (THPP) is a condition that results in transient skeletal 
muscle paralysis secondary to intracellular potassium sequestration. Susceptible individuals 
often have an underlying channelopathy, which may be exacerbated by lifestyle factors or 
underlying medical comorbidities such as hyperthyroidism or diarrheal illness. Classically, THPP 
presents with paralysis of proximal extremity musculature. In this case, we present a rare case 
of unilateral THPP. Such a presentation is relevant to emergency physicians as it mimics a 
stroke or transient ischemic attack and should be considered on the differential for unilateral 
neurologic deficits. [Clin Pract Cases Emerg Med. 2020;4(1):75–78.]
INTRODUCTION
Thyrotoxic hypokalemic periodic paralysis (THPP) is 
an endocrinologic disease that presents with acute episodic 
paralysis. In THPP, a thyroid-hormone-mediated cascade 
results in increased sodium/potassium (Na+/K+) pump activity 
leading to K+ sequestration inside the cell and subsequent 
muscular paralysis.1,2 Underlying electrolyte channel 
mutations predispose individuals to acquired periodic paralysis 
syndromes, and the thyrotoxic insult instigates the episodic 
paralysis.1 THPP classically presents with proximal muscle 
weakness, with the lower extremities typically affected to a 
greater extent than the upper extremities.1 Atypical findings 
such as asymmetric paralysis are rare, and there is a paucity 
of such presentations reported in the literature. We report an 
atypical case of unilateral weakness secondary to THPP, adding 
this diagnosis to the long differential that emergency physicians 
must consider among other stroke mimics.
CASE REPORT
A 48-year-old Caucasian male presented via emergency 
medical services (EMS) with sudden onset unilateral right-
sided weakness. The patient reported a heavy sensation in 
his muscles on the right side of his body and complained of 
difficulty manipulating his phone. The peak symptoms lasted 
about 3-5 minutes, and by the time EMS arrived, gross motor 
function had returned. The patient reported persisting, mild, 
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right-sided weakness on arrival to the emergency department 
(ED), but otherwise remained hemodynamically stable.
He reported a history of Grave’s disease controlled by 
methimazole and propranolol. Further history revealed a 
similar episode in December 2017 marked by generalized 
weakness and fasciculations. He had been found to have 
hyperthyroidism at that time and was started on propranolol, in 
addition to methimazole. His current medication list included 
methimazole, propranolol, telmisartan/hydrochlorothiazide, 
testosterone, albuterol, aspirin, and emtricitabine/tenofovir 
disoproxil. He also admitted to non-compliance with his high 
potassium diet and supplementation.   
Physical examination demonstrated 4/5 strength in both 
the right upper and lower extremities, as compared with 
5/5 strength on the left. Proximal and distal muscles were 
affected equally. The patient denied any sensory deficits. 
The EMS report described near-complete loss of right-sided 
motor function with rapid improvement en route to the 
hospital. Relevant laboratory testing demonstrated a K+ of 3.4 
milliequivalents per liter (mEq/L) (reference range 3.5-5.1 
mEq/L), normal blood glucose, a thyroid stimulating hormone 
(TSH) of 0.02 microinternational units per milliliter (uIU/ml) 
(reference range: 0.270-4.320 uIU/ml) and a free-thyroxine 
(T4) of 2.34 nanogram per deciliter (ng/dL) (reference range: 
0.80-1.80 ng/dL). Computed tomography (CT) of the head 
with and without angiography demonstrated periventricular 
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CPC-EM Capsule
What do we already know about this clinical 
entity? 
Thyrotoxic hypokalemic periodic paralysis 
(THPP) is marked by transient hypokalemia 
due to hyperthyroidism resulting in transient 
symmetric muscular paralysis.
What makes this presentation of disease 
reportable? 
THPP usually manifests as bilateral weakness. 
However, this case presented with unilateral 
weakness presenting as a stroke mimic.
What is the major learning point? 
THPP is a stroke mimic and should be 
considered on the differential in patients with 
thyroid conditions.
How might this improve emergency 
medicine practice? 
Physicians may now better identify this rare 
stroke mimic and initiate proper treatment 
while avoiding unnecessary testing.
and subcortical white matter densities, which were unchanged 
from prior imaging, but did not reveal any intracranial 
hemorrhage or flow-limiting lesions. His electrocardiogram 
(ECG) showed a right bundle-branch block, which was 
unchanged from prior ECGs. Subsequent outpatient testing for 
syphilis was negative.
The diagnosis of THPP was made in consultation with 
neurology based on past medical history, lab abnormalities, and 
negative CT/ CT angiography imaging. Given his near-complete 
recovery after several hours of observation and a near normal 
K+, we withheld K+ supplementation and propranolol in the ED. 
Endocrinology advised that he increase his methimazole and 
restart his high-potassium diet. The patient was discharged with 
endocrinology and neurology follow-up. Subsequent outpatient 
electroencephalogram performed by neurology in evaluation 
of atypical seizures was also negative. With compliance of his 
medications and high potassium diet, the patient has not had any 
additional episodes of paralysis.
DISCUSSION
THPP has a 0.1-0.2% prevalence in the United States, 
typically presenting with transient symmetric skeletal 
muscle paralysis, which usually affects the lower extremities 
disproportionately to the upper extremities.3,4,5  It occurs 
more frequently in Asian populations and typically presents 
in Asian men ages 20 to 40.3 Males are more susceptible 
than females, with reported ratios ranging from 17:1 to 
70:1.6 THPP is thought to be mediated through the Na+/K+ 
pump. Studies suggest that androgen-mediated promotion 
of the Na+/K+ pump and a larger muscle-to-body ratio lead 
to greater risk of  THPP episodes.1 In addition, estrogen 
decreases Na+/K+ pump activity, making females less 
susceptible to this syndrome. Hyperthyroidism upregulates 
the Na+/K+ pump expression on skeletal muscle in addition 
to increasing the pump activity.1,2,4 As a result, the cell 
sequesters K+ intracellularly, leading to the common pathway 
for many acquired paralysis syndromes: hypokalemia.6
Thyrotoxicosis alone, however, does not result in episodic 
paralysis, nor do free T4 levels correlate to symptoms.7 Rather, 
certain genetic factors in combination with a trigger such as 
thyrotoxicosis lead to clinical manifestation of the disease.8 
The potassium inwardly-rectifying channel subfamily 
J member 2 gene (KCNJ2) and potassium inwardly-
rectifying channel subfamily J member 18 gene (KCNJ18) 
are the two most prominent genes with mutations that 
predispose individuals to THPP in Asians and Caucasians, 
respectively.6 These genes are inward- rectifying K+ channels, 
which counteract the Na+/K+ pump by channeling K+ 
extracellularly.8 In mutated genes, excess thyroid hormone, 
excess catecholamines or excess insulin may all inhibit 
efflux of potassium from the cell, further sequestering K+ 
and contributing to intravascular hypokalemia.8 Other known 
triggers include large carbohydrate loads (excess insulin), 
exercise (excess catecholamines), stress, toxic adenomas, 
diuretics, fluoroquinolones, aminoglycosides, amiodarone, 
alcohol, and even licorice.2,8,9,10 
Presentations vary widely from mild, transient, self-
limited motor dysfunction to total flaccid paralysis including 
respiratory muscles.11,12,13 Bulbar and ocular symptoms have 
been reported in rare cases; however, it is unclear whether 
ocular involvement stems from THPP or the thyrotoxicosis.1,8 
This syndrome may even precipitate various dysrhythmias 
including ventricular fibrillation, ventricular tachycardia, 
atrioventricular block, or sinus arrest.14
Although existence of asymmetric THPP is suggested in 
the literature, a paucity of unilateral or asymmetric cases has 
been reported.1,15 A small 2012 case series of 11 patients with 
acquired hypokalemic periodic paralysis reported asymmetric 
weakness in three patients; however, all of these patients 
had acquired non-thyrotoxic hypokalemic periodic paralysis, 
whereas no patients with THPP had asymmetric weakness.15 
Treatment for THPP involves correction of K+ and returning 
the patient to a euthyroid state.1,2,6,14 
Care must be taken when correcting K+ as the patient 
has relative hypokalemia, in which the potassium is merely 
shifted into the cell instead of being depleted in the body.1,2 In 
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addition, similar to the presented patient who was borderline 
hypokalemic, one case of THPP with normokalaemia has 
been reported.2 This, however, may represent a redistribution 
of K+ back into the extra-cellular space at the time of the lab 
draw rather than true normokalemia at the time of symptom 
onset. Thus, potassium supplementation in the ED must 
be performed with care as 70-80% of patients treated with 
potassium have rebound hyperkalemia.6,14 Providers must 
also consider management of associated electrolytes such 
as magnesium when repleting potassium. Close cardiac 
monitoring is also essential since patients are at risk of both 
hypo and hyperkalemic-induced dysrhythmias.  
In the ED, a non-selective β-blocker such as propranolol 
is favored to reduce hyperthyroid symptoms and inhibit 
intracellular potassium sequestration.1,2 Selective β-blockers 
do not act on skeletal muscle, which makes them less useful in 
the management of THPP.1 One study demonstrated resolution 
of paralysis and normalization of the potassium within two 
hours of a three milligram per kilogram  dose of propranolol 
administration by mouth.16 After correction of the emergent 
episode, maintenance of a euthyroid state and outpatient 
follow-up is important in preventing recurrent paralytic 
episodes.6 This is critical for long-term management since 
repeated attacks may cause permanent muscle weakness.1 
CONCLUSION 
In this case, we report a rare presentation of THPP 
associated with transient, self-resolving, unilateral weakness. 
While non-thyrotoxic hypokalemic periodic paralysis has 
been associated with asymmetric weakness, only one source 
cites THPP with asymmetry.15 Additional pathologies such as 
familial periodic paralysis, stroke, transient ischemic attack, and 
neurosyphilis were investigated both in the ED and in follow-
up without evidence of another convincing etiology. Unilateral 
weakness in THPP is a rare stroke mimic. Nevertheless, it is 
an important diagnosis in the ED given that it requires prompt 
treatment, astute electrolyte management, and close cardiac 
monitoring, which sometimes may present a difference in 
priorities for stroke workups. TSH, rapid electrolyte testing, a 
history of hyperthyroidism, or a history of past similar episodes 
can help tip off a physician to this pathology.  
For emergency physicians, ensuring proper follow-up is 
essential since compliance with medications and management 
of the patient’s hyperthyroidism can prevent long-term 
morbidity such as persistent muscular weakness. No studies 
have researched the propensity for repeated paralytic episodes 
or long-term morbidity in populations with disparate degrees 
of healthcare access; however, special attention should be 
paid to the disposition and follow-up of THPP patients with 
poor healthcare access who may not have easy access to 
medications or a physician to make medication changes. 
As emergency physicians, we can make a lasting difference 
for these patients by prompt recognition and proper care 
in the ED, and via coordination of appropriate outpatient 
management for medical comorbidities.    
Documented patient informed consent and/or Institutional Review 
Board approval has been obtained and filed for publication of this 
case report.
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